Leukemic transformation of polycythemia vera: A single center study of 23 patients

Francesco Passamonti, Elisa Rumi, Luca Arcaini, Carlo Castagnola, Monia Lunghi, Paolo Bernasconi, Matteo Giovanni Della Porta, Nora Columbo, Cristiana Pascutto, Mario Cazzola, Mario Lazzarino

Research output: Contribution to journalArticle

Abstract

BACKGROUND. Acute leukemia (AL) may occur as rare and late event of polycythemia vera (PV). METHODS. The current study included 23 patients who developed acute leukemia in a cohort of 414 consecutive PV patients with long-term observation (3208 person years of follow-up), Kaplan-Meier Product-Limit method was used to estimate the cumulative probability of survival; Gehan-Wilcoxon test was applied to compare survival in different groups of patients. RESULTS. Median age was 68 years, and 18 patients (78%) were > 60 years of age. At diagnosis of AL, most patients had a white blood count > 10 × 10 9/L (n = 17; 74%), Hgb <10 g/dL (n = 13; 57%), and platelet count > 50 × 10 9/L (n = 17; 74%). Of 14 patients in whom cytogenetic analysis was available at leukemia transformation, 12 showed high-risk abnormalities including complex karyotype (n = 10), del (7)(q22) sole (n = 1) and del (X)(q26) sole (n = 1), whereas 2 had a normal karyotype. In patients whose karyotype was available at diagnosis of PV, cytogenetic evolution was documented at progression to AL. Treatment consisted of supportive care and/or low-dose chemotherapy (n = 15), or induction chemotherapy (n = 8). This included idarubicin plus cytarabine (n = 3), high-dose cytarabine (n = 4), and fludarabine-based regimen (n = 1). Allogenic stem cell transplantation was offered to a single patient, who is alive at Day + 70. The outcome of patients was poor, with a median survival of 2.9 months (range, 0.6-20.1 mos), with no significant differences between palliation and intensive treatments. CONCLUSIONS. AL following PV has distinct clinical and biologic features. Outcome of patients is poor irrespective of the treatment employed.

Original languageEnglish
Pages (from-to)1032-1036
Number of pages5
JournalCancer
Volume104
Issue number5
DOIs
Publication statusPublished - Sep 1 2005

Keywords

  • Acute leukemia
  • Chronic myeloproliferative disorders
  • Essential thrombocythemia
  • Myelofibrosis
  • Polycythemia vera

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Leukemic transformation of polycythemia vera: A single center study of 23 patients'. Together they form a unique fingerprint.

  • Cite this